Congenital hepatic arteriovenous malformations are rare anomalies, which typically present in infancy with congestive heart failure, anemia, and hepatomegaly. Morbidity and mortality is high if the condition is not recognized and treated promptly. Hepatic arteriovenous malformation associated with persistent pulmonary hypertension of the newborn has been reported in two cases in the literature. We report a neonate who was referred for management of persistent pulmonary hypertension and was subsequently diagnosed with a large hepatic arteriovenous malformation. He underwent coil embolization following which pulmonary hypertension resolved.
Introduction
Persistent pulmonary hypertension of the newborn (PPHN) is commonly associated with pulmonary parenchymal pathology, sepsis, lung hypoplasia or congenital cardiac defects. 1 Peripheral arterio-venous malformations (AVM) in the newborn are rare anomalies that can be associated with PPHN and can result in significant morbidity and mortality if not diagnosed early. 2 We report one such instance, where a term newborn presenting as PPHN was later diagnosed with a hepatic AVM (HAVM).
Case presentation
A term male infant with a birth weight of 3.6 kg was delivered vaginally by a 28-year-old primigravida whose pregnancy was remarkable for GBS colonization. Intrapartum antibiotics were administered for suspected chorioamnionitis. Apgar scores were 9 and 9 at 1 and 5 min, respectively. Physical examination at delivery revealed bounding femoral pulses. Complete blood count was within normal limits. At 2 h of age, he required supplemental oxygen for desaturations. Chest X-ray was unremarkable. A complete sepsis work-up was carried out and parenteral antibiotic therapy initiated in view of progressively increasing respiratory distress at 15 h of age. Detection of a systolic murmur prompted an echocardiographic evaluation at 20 h of age. This revealed normal cardiac anatomy and severe pulmonary hypertension. A provisional diagnosis of PPHN secondary to sepsis was entertained. The baby was treated with mechanical ventilation, pressors, midazolam, fentanyl and pancuronium. He was transferred to the Children's Hospital of Michigan at 38 h of age for treatment of refractory PPHN. Inhaled nitric oxide (INO) was started during transport with improvement in oxygenation.
Physical examination at admission showed an intubated sedated infant with a hyperactive precordium, systolic murmur and hepatomagaly. There were no bruits. Blood and spinal fluid cultures were sterile. Cardiomegaly and pulmonary congestion were noted on a repeat chest radiograph. Echocardiogram revealed severely dilated right-sided structures, suprasystemic right ventricular pressures, accelerated blood flow within the inferior vena cava, and an incidental finding of a large HAVM. An abdominal ultrasound confirmed the presence of a massive HAVM involving predominantly the left lobe of the liver with extension into the right lobe. Inhaled nitric oxide was discontinued and intravenous furosemide was started.
Angiography showed a complex, extensive HAVM fed predominantly by an enlarged left hepatic artery and by a few abnormal branches from the right hepatic and cystic arteries (Figures 1 and 2 ). Coil embolization of 80% of the HAVM was accomplished within 6 h of admission followed by marked decrease in flow through the HAVM (Figure 3 ). Collaterals arising directly from the aorta above the celiac axis and the left inferior epigastric artery were identified but could not be catheterized for embolization. Following the procedure, he was successfully weaned from pressors and mechanical ventilation. Repeat angiography performed on the 12th postnatal day showed persistent flow to the HAVM from two feeder vessels arising near the celiac axis.
He was extubated on the 14th day of life and discharged home at 26 days of age. Serial echocardiograms showed complete resolution of pulmonary hypertension and decongestive therapy was discontinued. He continues to do well with appropriate growth parameters.
Discussion PPHN may be associated with diverse conditions resulting in either increased pulmonary vascular resistance (PVR) or pulmonary blood flow (PBF). The key pathophysiologic component of PPHN is almost always elevated PVR. There are very few conditions in which increased PBF is an important component of PPHN. Infants with large peripheral AVM may display pulmonary hypertension because of a mandatory increase in PBF superimposed on the elevated neonatal PVR. 1 AVM that produce symptoms in the first 6 months of life are seen primarily in the central nervous system, lung and liver. 2 Neonatal hyperthyroidism may also present with high output cardiac failure and PPHN. 3 Although PPHN has been reported in neonates with cerebral AVM (CAVM), [4] [5] [6] [7] [8] there are only two reports in the literature of congenital HAVM associated with PPHN. 9, 10 Congenital HAVM are rare anomalies that most commonly (58%) present with congestive heart failure (CHF) at an early age (mean 2.2 months). 11 Other presenting features include hepatomegaly, consumptive coagulopathy, anemia, portal hypertension and hydrops fetalis. 12 Although PPHN has been reported as the initial diagnosis in four infants with CAVM, 4, 6, 7 it has not been reported as the primary presentation of HAVM. The case, we present is unique because the baby was referred for management of PPHN refractory to treatment. The combination of a brisk pulse, heart failure, and absence of any major cardiac lesion or echocardiographic finding of significantly accelerated blood flow within the superior, or inferior vena cava in the presence of a structurally normal heart should thus alert one to look for an AVM in a neonate. 13 The treatment of PPHN is dictated by the underlying pathophysiologic mechanism. Although pulmonary vasodilators (INO) may be useful in the treatment of PPHN resulting from increased PVR, we believe that their use in infants with increased PBF may worsen the symptoms of CHF. Treatment of PPHN due to HAVM involves medical management of CHF and definitive treatment of the underlying cause, that is, hepatic artery embolization or ligation, partial hepatic resection and orthotopic liver transplantation.
2,10 -15 Surgical resection or ligation of the feeding artery is associated with significant risk in sick infants with extensive HAVM and multiple collaterals as in our patient. Successful transcatheter embolization as definitive therapy has been described in two neonates with HAVM both of whom survived. Embolization is most effective in patients with a single arteriovenous fistula. In neonates with multiple collaterals, embolization may improve outcomes in severely ill patients. Orthotopic liver transplant may be the only recourse for those infants with HAVM and multiple collaterals who do not respond to transcatheter embolization and whose lesion is not amenable to surgical resection.
Although rare, HAVM have a 50-90% mortality emphasizing the importance of a high index of suspicion for early diagnosis and definitive treatment. 2, 12, 15 We suggest that echocardiographic evaluation of PPHN should also include a careful evaluation of the liver to rule out HAVM.
In conclusion, we report a term neonate with HAVM presenting with severe PPHN. He responded to transcatheter coil occlusion of the main feeder vessel with complete resolution of right heart failure and pulmonary hypertension.
